Clinical trial
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon…
NCT00381381 · Eisai Korea Inc., Industry · Completed
Key facts
| NCT number | NCT00381381 |
|---|---|
| Title | The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease |
| Official title | A Multi-center Study for the Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease |
| Lead sponsor | Eisai Korea Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Donepezil |
| Enrollment | 199 |
| Start date | May 31, 2006 |
| Primary completion | Aug 31, 2008 |
| Completion | Dec 31, 2008 |
| First posted | Sep 27, 2006 |
| Last update posted | Jan 4, 2022 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: